Morgan Stanley Adjusts Price Target on Synopsys to $525 From $480, Maintains Equalweight Rating - marketscreener.com

Morgan Stanley has raised Synopsys' price target from $480 to $525 while maintaining its equalweight rating, reflecting confidence in the company's leadership in semiconductor design tools and its rol... Read original →

Morgan Stanley’s price target hike for Synopsys underscores the inflexible demand for high-fidelity EDA tools at 3nm and below. Technically, this accelerates AI-enhanced simulation adoption across foundries like SMIC and Samsung, pressuring Cadence and Siemens EDA to embed generative AI faster. On compliance, U.S. export controls indirectly inflate Synopsys’ China operational costs, forcing IP licensing restructuring—especially for cross-authorization between clients in Taiwan, China and mainland China—to avoid BIS scrutiny. Competitively, Cadence may counter with cloud-integrated pricing (e.g., deeper AWS bundling), while Chinese rivals like Huada Empyrean exploit mature-node niches. Over the next 12–24 months, Synopsys’ real tailwind lies not in standalone tools but in its closed-loop data infrastructure spanning design, fabrication, and packaging—the scarcest asset in the AI chip boom.